Delivery Order SPE2DB20D2104-SPE2DB25F1290

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FH9NP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567461288 ! CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $9,759.63 and a completion date of March 5, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation, indicating open...
This federal contract award, with the ID SPE2DB20D2200|SPE2DB24FX16W, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,495.10 delivery order contract is for the provision of 4565964986 CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of September 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHAK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,234.07 firm fixed-price delivery order is for the supply of 4567105245 ! CARVEDILOL ER 20 MG CAPSULE 30S, a type of cardiovascular medication. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with an ID of SPE2DB24D2205|SPE2DB25FDYFM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567237430 ! CARVEDILOL ER 10 MG CAPSULE 30S, a pharmaceutical product, and has a ceiling value of $13,751.14. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 12, 2025. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,975.84, is a delivery order for the provision of 4568078484 CARVEDILOL ER 20 MG CAPSULE 30S. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with the ID SPE2DB20D1100|SPE2DB24FB9V3, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The $3,938.22 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established a significant...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,512.38 Firm Fixed Price Delivery Order contract is for the supply of 4566736632 CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication. The contract has a ceiling value of $4,512.38 and a completion date of December 17, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB22D1103 and SPE2DB25FTDZ3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,521.04 firm fixed-price delivery order is for the supply of CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPV38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,597.67 firm fixed-price delivery order is for the supply of 4567503207 - CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with the ID SPE2DB22D1103|SPE2DB25FTFP7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567265545 ! CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $1,872.12 and a completion date of February 14, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25F1290
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB25F1290, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $4,015.57, is for the delivery of 4566367897 ! CARVEDILOL ER 10 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 1:57 PM